vinpocetine

Known as: eburnamenine-14-carboxylic acid, ethyl ester, (3 alpha,16 alpha)-, ethyl apovincaminate, vinpocetine [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Atherosclerosis, the major cause of myocardial infarction and stroke, is a chronic arterial disease characterized by lipid… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Vinpocetine (Vin) existing oral formulations suffer poor bioavailability (∼7%) since Vin undergoes a marked first-pass effect… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Inflammation is a hallmark of many diseases, such as atherosclerosis, chronic obstructive pulmonary disease, arthritis… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The purpose of this study is to develop an optimized nanostructured lipid carriers (NLC) formulation for vinpocetine (VIN), and… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Enhancing cyclic nucleotides signaling by inhibition of phosphodiesterases (PDEs) is known to be beneficial in disorders… (More)
Is this relevant?
2008
2008
A new self-microemulsifying drug delivery system (SMEDDS) has been developed to increase the solubility, dissolution rate and… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
An ultrasonic-solvent emulsification technique was adopted to prepare vinpocetine loaded Glyceryl monostearate (GMS… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2002
2002
Oxygen-free radicals play an important role in several physiologic and pathophysiologic processes. In pathologic circumstances… (More)
Is this relevant?
1985
1985
Twelve healthy female volunteers received pre-treatments with vinpocetine 10, 20, 40 mg and placebo (t.d.s.) for two days… (More)
  • table 1
  • figure 2
  • figure 1
Is this relevant?
1984
1984
A novel vasodilating agent, vinpocetine (14-ethoxycarbonyl-(3 alpha,16 alpha-ethyl)-14,15-eburnamenine) inhibits Ca2+-dependent… (More)
Is this relevant?